Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings

Deciphera Pharmaceuticals, Inc. (DCPH) reported $45 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 34.5%. EPS of -$0.52 for the same period compares to -$0.60 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $45.99 million, representing a surprise of -2.15%. The company delivered an EPS surprise of +5.45%, with the consensus EPS estimate being -$0.55.While investors closely watch year-over-year changes in headline numbers -- revenue ...